RG7287
Gecertificeerd

RG7287

Catalog #: HY-P991226-01
Maat: 1 mg
Droogijs Vereist

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Description

RG7287 is an activating antibody inhibitor targeting human CDCP1. RG7287 prevents the loss of contact inhibition caused by the co-transformation of NIH3T3 cells with CDCP1 and Src in focus formation assays. RG7287 inhibits tumor cell proliferation and leads to a significant reduction in CDCP1 levels[1].

UNSPSC

12352203

Hazard Statement

H302, H315, H319, H335

Target

Others

Related Pathways

Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Purity

97.666

Smiles

[RG7287]

Precautions

H302, H315, H319, H335

References & Citations

[1]Gwendlyn Kollmorgen, et al. Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy. Mol Oncol. 2013 Dec;7 (6) :1142-51.

Shipping Conditions

Dry Ice

Storage Conditions

-80°C

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-P991226/RG7287-SDS-MedChemExpress.pdf

Scientific Category

Inhibitory Antibodies

Clinical Information

No Development Reported

Beschrijving

RG7287 is an activating antibody inhibitor targeting human CDCP1. RG7287 prevents the loss of contact inhibition caused by the co-transformation of NIH3T3 cells

Specificaties

ProductnaamRG7287
Categorie
Beschikbare grootte1 mg
CatalogusnummerHY-P991226-01